How to manage steroid diabetes in the patient with cancer.
Oyer
David S
DS
Division of Endocrinology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA. d-oyer@northwestern.edu
Shah
Ajul
A
Bettenhausen
Susan
S
D000970:Antineoplastic Agents / Q000009:adverse effects*; D001786:Blood Glucose / Q000187:drug effects / Q000378:metabolism; D003907:Dexamethasone / Q000009:adverse effects; D003920:Diabetes Mellitus / Q000139:chemically induced* / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D006943:Hyperglycemia / Q000139:chemically induced / Q000188:drug therapy; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000627:therapeutic use; D007333:Insulin Resistance; D013256:Steroids / Q000009:adverse effects*
D000970:Antineoplastic Agents; D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D013256:Steroids; D003907:Dexamethasone